Core Viewpoint - The medical temperature control blanket is becoming an essential part of healthcare institutions, effectively alleviating patient pain and swelling, promoting wound healing, and protecting brain cells during hypothermia treatment, thereby reducing mortality and disability rates [1][11]. Industry Overview - The medical temperature control blanket is a medical device that regulates patient body temperature through a water circulation system and related components. It is widely used in neurosurgery, ICU, and neurology departments [3][11]. - The market size of China's medical temperature control blanket industry has been growing, from 0.62 million yuan in 2019 to an expected 1.13 million yuan in 2024, with a compound annual growth rate (CAGR) of 12.6% [1][11]. Industry Chain - The upstream of the medical temperature control blanket industry includes components such as temperature control systems, control systems, water circulation systems, and shell components. The midstream consists of manufacturers, while the downstream includes various medical institutions and distributors [5][11]. Market Demand - The demand for medical temperature control blankets is increasing due to the rising number of healthcare institutions, which is projected to reach 1,093,600 by 2024, an increase of 22,800 from 2023, representing a year-on-year growth of 2.13% [9][11]. Competitive Landscape - The industry is characterized by intense competition, with many companies focusing on product quality and after-sales service to capture market share. Key players include Henan Huashi Industrial Co., Ltd., Hangzhou Rewei Medical Co., Ltd., and others [13][14]. Development Trends - The demand for medical temperature control blankets is expected to continue increasing due to the aging population and the rise in chronic diseases, which require long-term management and treatment [19]. - Future advancements may include smart features enabled by artificial intelligence and IoT technology, allowing for precise temperature control and automatic adjustments [20]. - The industry is likely to focus on personalized temperature control solutions tailored to individual patient needs, enhancing treatment effectiveness and comfort [22].

Core Viewpoint - The article highlights the successful development and approval of the TMS100 system by Zhipu Medical Technology, marking a significant advancement in China's medical device industry, particularly in precise temperature management for critical medical scenarios [1][2]. Company Summary - Zhipu Medical Technology has developed the TMS100 system, which is the first domestic precision temperature control treatment device approved for market use in China [1]. - The TMS100 system utilizes innovative multi-modal adaptive temperature control algorithms and an intelligent risk warning platform, achieving a temperature control precision of ±0.1°C, which meets international standards [1]. - The company aims to provide more efficient and precise treatment tools for clinicians while reducing medical costs and benefiting more patients [2]. Industry Summary - Chengdu Tianfu International Bio-city is focusing on high-quality development in the medical device industry, targeting segments such as in vitro diagnostics, interventional products, medical materials, and life support devices [2]. - The bio-city has attracted major companies like GE Healthcare and MaiKe Bio, fostering the development of significant medical devices that fill gaps in both domestic and international markets [2]. - Future plans for Chengdu Tianfu International Bio-city include promoting the integration of production and research in the medical device industry and accelerating the transformation of scientific achievements [2].